Non-alcoholic fatty liver disease in an area of southern italy: Main clinical, histological, and pathophysiological aspects

Journal of Hepatology

Volumn 35, Issue 5, 2001, Pages 568-574

  Loguercio, Carmela ^a,e   De Girolamo, Vincenzo ^a   De Sio, Ilario ^a   Tuccillo, Concetta ^a   Ascione, Antonio ^b   Baldi, Feliciano ^a   Budillon, Gabriele ^c   Cimino, Lucia ^c   Di Carlo, Antonio ^c   Pia Di Marino, Maria ^a   Morisco, Filomena ^d   Picciotto, Francesco ^b   Terracciano, Luigi ^c   Vecchione, Raffaella ^c   Verde, Veronica ^d   Del Vecchio Blanco, Camillo ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e NONE   (Italy)

Author keywords

Liver steatosis; Non alcoholic fatty liver disease; Steatohepatitis

Indexed keywords

4 HYDROXYNONENAL; ANTIOXIDANT; MALONALDEHYDE;

ADULT; ARTICLE; BODY MASS; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FATTY LIVER; FEMALE; HEPATITIS; HUMAN; HYPERINSULINEMIA; ITALY; LIPID PEROXIDATION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEX RATIO;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ALCOHOL DRINKING; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL; DIABETES MELLITUS; ENERGY INTAKE; FATTY LIVER; FEMALE; HUMANS; INSULIN; IRON; ITALY; LIVER DISEASES; MALE; MALONDIALDEHYDE; MIDDLE AGED; SEX CHARACTERISTICS; TRIGLYCERIDES;

EID: 0035164629     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00192-1     Document Type: Article

References (48)

1. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years
2. Non-alcoholic steatohepatitis: An expanded clinical entity
3. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients
4. The natural history of nonalcoholic fatty liver: A follow-up study
5. Nonalcoholic steatohepatitis
6. Nonalcoholic steatohepatitis (NASH): A disease of emerging identity and importance
7. General aspects of drug-induced liver disease
8. Smokeless tobacco-induced increase in hepatic lipid peroxidation. DNA damage and excretion of urinary lipid metabolites
9. Forward and reverse catalysis and product sequestration by human glutathione-S-transferase in the reaction of GSH with dietary aralkyl isothiocyanate
10. Aflatoxin exposure in human populations: Measurements and relationship to cancer
11. Nonalcoholic steatohepatitis in obesity. A reversible condition
12. Liver pathology in morbidly obese patients with and without diabetes
13. Non-alcoholic steatohepatitis: Association with obesity and insulin resistance, and influence of weight loss
14. Acute and chronic steatosis lead to in vivo lipid peroxidation in mice
15. Microvesicular steatosis and steatohepatitis: Role of mitochondrial dysfunction and lipid peroxidation
16. Hepatic cytochrome P450 2E1 is increased in patients with non-alcoholic steatohepatitis
17. Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes
18. Pathogenetic factors in cirrhosis with and without hepatocellular carcinoma: A multicenter Italian study
19. Attributable risk for symptomatic liver cirrhosis in Italy
20. Non-alcoholic steatohepatitis in an area with high prevalence of chronic viral hepatitis Abstract
21. Drinking habits of subjects with HCV-related chronic liver disease: The prevalence and effect on clinical, virological and pathological aspects
22. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis
23. Diabetes mellitus
24. Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: A study of 192 cases
25. Hepatic iron and non-alcoholic fatty liver disease
26. Relationship between impaired glucose tolerance, non-insulin-dependent diabetes mellitus and obesity
27. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis
28. Association between hepatic steatosis, insulin resistance and hyperinsulinemia as related to hypertension in alcohol consumers and obese people
29. Mitochondrial abnormalities in non-alcoholic steatohepatitis
30. 2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase
31. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation
32. Cytochrome P450 2E1 inducibility and hydroxyethyl radical formation among alcoholics
33. Changes in microsomal activity in alcoholism and obesity
34. Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: Potential mechanism for sensitization to liver damage
35. Role of cytochrome P450 2E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol
36. Antioxidants, vitamin intake and coronary mortality in a longitudinal population study
37. Diabetes mellitus. A free radical associated disease: Effects of adjuvant supplementation of antioxidants
38. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver
39. Non-alcoholic steatohepatitis
40. Increased hepatic iron concentration in non-alcoholic steatohepatitis is associated with increased fibrosis
41. Insulin: New roles for an ancient hormone
42. Non-alcoholic steatohepatitis and iron: Increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis
43. Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis Abstract
44. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis
45. Non-alcoholic steatohepatitis Letter
46. Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology
47. Ursodeoxycholic acid or clofibrate in the treatment of non-alcoholic-induced steatohepatitis: A pilot study